Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Smith Michael AlexanderChief Legal Officer
|
GrantCommon Stock | 5,706 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,284 F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 1,064 | $66.21 | $70,447.44 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,578 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Adsett RogerChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 31,930 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · derivative · entry 6 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,930 Underlying: Common Stock · 31,930 shares Expires 2035-01-08 F7 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 6,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,441 F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 1,882 | $66.10 | $124,400.20 |
DisclosureSEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,784 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 3,344 | $65.91 | $220,403.04 |
DisclosureSEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,766 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 3,344 shares sold at prices ranging from $65.57 to $65.99 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Due to a clerical error related to the reporting of shares previously withheld by the Company to satisfy tax obligations upon the vesting of RSUs, this number was previously overstated by 24 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 24 shares. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 3,470 | $65.70 | $227,979.00 |
DisclosureSEC source: 0001628280-25-001206 · wk-form4_1736552720.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,736 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 3,470 shares sold at prices ranging from $65.69 to $65.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Includes 725 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 2,596 | $65.88 | $171,024.48 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,515 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,596 shares sold at prices ranging from $65.72 to $65.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Includes 11 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.07 | $0.00 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · derivative · entry 7 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 2,908 | $65.87 | $191,549.96 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 3 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,584 F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F4 · price: This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 10,000 | $65.98 | $659,800.00 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,492 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
Exercise / conversionCommon Stock | 10,000 | $16.07 | $160,700.00 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 8,218 | $66.02 | $542,552.36 |
DisclosureSEC source: 0001628280-25-001203 · wk-form4_1736552690.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,742 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 8,218 shares sold at prices ranging from $66.00 to $66.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:44 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 2,306 | $65.98 | $152,149.88 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,642 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,306 shares sold at prices ranging from $65.96 to $66.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Includes 92 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:44 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 2,444 | $65.95 | $161,181.80 |
DisclosureSEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,666 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,444 shares sold at prices ranging from $65.85 to $66.21 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · derivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 225,460 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · derivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 18,750 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,830 | $69.86 | $477,143.80 |
DisclosureSEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 6,830 shares sold at prices ranging from $69.48 to $70.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 18,750 | $69.84 | $1,309,500.00 |
DisclosureSEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,960 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 18,750 shares sold at prices ranging from $69.45 to $70.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · derivative · entry 9 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 232,290 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · derivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 18,750 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,590 | $70.61 | $112,269.90 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 1,590 shares sold at prices ranging from $70.36 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 5,240 | $69.71 | $365,280.40 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 235,514 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 5,240 shares sold at prices ranging from $69.28 to $70.27 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 5,588 | $70.52 | $394,065.76 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,960 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 5,588 shares sold at prices ranging from $70.23 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 13,162 | $69.65 | $916,733.30 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 390,548 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 13,162 shares sold at prices ranging from $69.22 to $70.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · derivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 239,120 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · derivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,250 Underlying: Common Stock · 18,750 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 181 | $74.22 | $13,433.82 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: This is the weighted average sales price representing 181 shares sold at prices ranging from $74.20 to $74.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,562 | $73.55 | $188,435.10 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 234,105 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 2,562 shares sold at prices ranging from $73.16 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 4,087 | $72.57 | $296,593.59 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 236,667 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 4,087 shares sold at prices ranging from $72.05 to $73.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 399 | $74.23 | $29,617.77 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,960 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 399 shares sold at prices ranging from $74.18 to $74.36 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,847 | $73.56 | $503,665.32 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,359 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 6,847 shares sold at prices ranging from $73.16 to $74.14 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 11,504 | $72.58 | $834,960.32 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,206 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 11,504 shares sold at prices ranging from $72.05 to $73.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| September 16, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,436 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · derivative · entry 9 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,680 Underlying: Common Stock · 13,436 shares Expires 2031-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| September 16, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 13,436 | $74.92 | $1,006,625.12 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 6 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,134 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 16, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionCommon Stock | 13,436 | $34.03 | $457,227.08 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 5 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · derivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 9,000 | $74.75 | $672,750.00 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,856 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 9,000 shares sold at prices ranging from $74.61 to $74.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 18,871 | $74.16 | $1,399,473.36 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,856 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 18,871 shares sold at prices ranging from $73.61 to $74.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 7,000 | $22.76 | $159,320.00 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 26,969 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · derivative · entry 8 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,116 Underlying: Common Stock · 26,969 shares Expires 2031-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 26,969 | $74.90 | $2,019,978.10 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 4 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,134 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionCommon Stock | 26,969 | $34.03 | $917,755.07 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 20:46 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 635 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · derivative · entry 7 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,085 Underlying: Common Stock · 635 shares Expires 2031-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.